Technical Analysis for OVID - Ovid Therapeutics Inc.

Grade Last Price % Change Price Change
grade D 2.24 -5.49% -0.13
OVID closed down 5.49 percent on Wednesday, July 17, 2019, on 63 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical OVID trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -5.49%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.49%
Wide Bands Range Expansion -5.49%
Wide Bands Range Expansion -12.84%
Overbought Stochastic Strength -12.84%

Older signals for OVID ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid is developing OV101 for use in both Angelman syndrome and Fragile X syndrome to potentially restore tonic inhibition and relieve several of the symptoms of these disorders. Ovid has initiated the Phase II STARS trial of OV101 in adults with Angelman syndrome and a Phase I trial in adolescents with Angelman syndrome or Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies.
Biopharmaceutical Organ Systems Disorders Neurological Disorders Epilepsy Genodermatoses Sedatives Anticonvulsants Fragile X Syndrome Syndromes
Is OVID a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.02
52 Week Low 1.53
Average Volume 427,769
200-Day Moving Average 2.9461
50-Day Moving Average 1.925
20-Day Moving Average 2.269
10-Day Moving Average 2.603
Average True Range 0.1966
ADX 30.96
+DI 30.0469
-DI 26.2915
Chandelier Exit (Long, 3 ATRs ) 2.3602
Chandelier Exit (Short, 3 ATRs ) 2.2598
Upper Bollinger Band 3.0603
Lower Bollinger Band 1.4777
Percent B (%b) 0.48
BandWidth 69.748788
MACD Line 0.1893
MACD Signal Line 0.2103
MACD Histogram -0.0209
Fundamentals Value
Market Cap 55.1 Million
Num Shares 24.6 Million
EPS -4.85
Price-to-Earnings (P/E) Ratio -0.46
Price-to-Sales 0.00
Price-to-Book 1.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.53
Resistance 3 (R3) 2.54 2.47 2.48
Resistance 2 (R2) 2.47 2.39 2.46 2.46
Resistance 1 (R1) 2.35 2.35 2.32 2.34 2.45
Pivot Point 2.28 2.28 2.26 2.27 2.28
Support 1 (S1) 2.16 2.20 2.13 2.15 2.03
Support 2 (S2) 2.09 2.16 2.08 2.02
Support 3 (S3) 1.97 2.09 2.00
Support 4 (S4) 1.96